Key result
Percutaneous coronary intervention was associated with a reduced risk of the composite outcome of all-cause mortality, recurrent myocardial infarction, and stroke at 3 months.
Why the study?
There is limited evidence on NSTE-ACS in patients aged 80 or older in Vietnam, and the effect of PCI on adverse outcomes in this group required examination.
Does percutaneous coronary intervention reduce the composite of all-cause mortality, recurrent myocardial infarction, and stroke in patients aged 80 years or older with non-ST elevation acute coronary syndrome?
Observational (n=120)
Yes
Does percutaneous coronary intervention reduce the composite of all-cause mortality, recurrent myocardial infarction, and stroke in patients aged 80 years or older with non-ST elevation acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
In patients aged 80 years or older with NSTE-ACS, PCI was associated with a significantly lower risk of the composite of all-cause mortality, recurrent MI, and stroke at 3 months compared to conservative management.
BACKGROUND: There is limited evidence of non-ST elevation acute coronary syndrome (NSTE-ACS) in patients aged 80 or older in Vietnam. AIM: To describe the clinical characteristics of patients aged≥80 with NSTE-ACS in Vietnam, and to examine the effect of percutaneous coronary intervention (PCI) on adverse outcomes. METHODS: Consecutive patients aged ≥80 with a diagnosis of NSTE-ACS admitted to two tertiary hospitals in Vietnam from 12/2018 to 06/2019 were recruited. The major outcomes were: (1) the composite of all-cause mortality, recurrent myocardial infarction and stroke, (2) re-admission rate during 3 months. Cox proportional-hazards regressions were conducted to examine the impact of PCI on the study outcomes, with results presented as hazard ratios (HR) and 95% confidence intervals (CI). RESULTS: There were 120 participants, mean age 84.8 ± 3.8, 50% were female. Angiography and PCI were performed in 42 participants (35.0%). Most of the participants had multimorbidity and multiple coronary vessel disease. Compared to participants who did not receive PCI, participants who received PCI had significantly lower rates of adverse events during hospitalisation and during 3 months of follow up. Cox proportional hazards models adjusted to age and GRACE score show that PCI was significantly associated with reduced the composite outcome of all-cause mortality, recurrent myocardial infarction and stroke during 3 months follow-up (adjusted HR 0.32, 95%CI 0.12-0.86). PCI was also associated with reduced re-admission. CONCLUSIONS: The rate of PCI was low in the very elderly patients with NSTE-ACS in this study, although PCI was significantly associated with reduced adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2020) conducted an observational in Non-ST elevation acute coronary syndrome (NSTE-ACS) (n=120). Percutaneous coronary intervention (PCI) vs. No PCI (conservative treatment) was evaluated on Composite of all-cause mortality, recurrent myocardial infarction and stroke during 3 months (adjusted HR 0.32, 95% CI 0.12-0.86, p=0.003). Percutaneous coronary intervention was associated with a reduced risk of the composite outcome of all-cause mortality, recurrent myocardial infarction, and stroke at 3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: